Literature DB >> 25461657

Infective endocarditis in Turkey: aetiology, clinical features, and analysis of risk factors for mortality in 325 cases.

Serap Şimşek-Yavuz1, Ayfer Şensoy2, Hulya Kaşıkçıoğlu3, Sabahat Çeken2, Denef Deniz2, Atilla Yavuz4, Funda Koçak5, Kenan Midilli6, Mehmet Eren3, İbrahim Yekeler7.   

Abstract

OBJECTIVE: In order to define the current characteristics of infective endocarditis (IE) in Turkey, we evaluated IE cases over a 14-year period in a tertiary referral hospital.
METHODS: All adult patients who were hospitalized in our hospital with a diagnosis of IE between 2000 and 2013 were included in the study. Modified Duke criteria were used for diagnosis. The Chi-square test, Student's t-test, Mann-Whitney U-test, Cox and logistic regression analysis were used for the statistical analysis.
RESULTS: There were 325 IE cases during the study period. The mean age of the patients was 47 years. Causative microorganisms were identified in 253 patients (77.8%) and included staphylococci (36%), streptococci (19%), enterococci (7%), and Brucella spp (5%). A streptococcal aetiology was associated with younger age (<40 years) (p=0.001), underlying chronic rheumatic heart disease (CRHD) (odds ratio (OR) 3.89) or a congenital heart defect (OR 4.04), community acquisition (OR 17.93), and native valve (OR 3.68). A staphylococcal aetiology was associated with healthcare acquisition (OR 2.26) or pacemaker lead-associated endocarditis (OR 6.63) and an admission creatinine level of >1.2mg/dl (OR 2.15). Older age (>50 year) (OR 3.93), patients with perivalvular abscess (OR 9.18), being on dialysis (OR 6.22), and late prosthetic valve endocarditis (OR 3.15) were independent risk factors for enterococcal IE. Independent risk factors for mortality in IE cases were the following: being on dialysis (hazard ratio (HR) 4.13), presence of coronary artery heart disease (HR 2.09), central nervous system emboli (HR 2.33), and congestive heart failure (HR 2.15). Higher haemoglobin (HR 0.87) and platelet (HR 0.996) levels and surgical interventions for IE (HR 0. 33) were found to be protective factors against mortality.
CONCLUSIONS: In Turkey, IE occurs in relatively young patients and Brucella spp should always be taken into consideration as a cause of this infection. We should first consider streptococci as the causative agents of IE in young patients, those with CRHD or congenital heart valve disease, and cases of community-acquired IE. Staphylococci should be considered first in the case of pacemaker lead IE, when there are high levels of creatinine, and in cases of healthcare-associated IE. Enterococci could be the most probable causative agent of IE particularly in patients aged >50 years, those on dialysis, those with late prosthetic valve IE, and those with a perivalvular abscess. The early diagnosis and treatment of IE before complications develop is crucial because the mortality rate is high among cases with serious complications. The prevention of bacteraemia with the measures available among chronic haemodialysis patients should be a priority because of the higher mortality rate of subsequent IE among this group of patients.
Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Aetiology; Infective endocarditis; Mortality risk factors

Mesh:

Year:  2014        PMID: 25461657     DOI: 10.1016/j.ijid.2014.11.007

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  13 in total

1.  Portraying infective endocarditis: results of multinational ID-IRI study.

Authors:  Hakan Erdem; Edmond Puca; Yvon Ruch; Lurdes Santos; Nesrin Ghanem-Zoubi; Xavier Argemi; Yves Hansmann; Rahmet Guner; Gilda Tonziello; Jean-Philippe Mazzucotelli; Najada Como; Sukran Kose; Ayse Batirel; Asuman Inan; Necla Tulek; Abdullah Umut Pekok; Ejaz Ahmed Khan; Atilla Iyisoy; Meliha Meric-Koc; Ayse Kaya-Kalem; Pedro Palma Martins; Imran Hasanoglu; André Silva-Pinto; Nefise Oztoprak; Raquel Duro; Fahad Almajid; Mustafa Dogan; Nicolas Dauby; Jesper Damsgaard Gunst; Recep Tekin; Deborah Konopnicki; Nicola Petrosillo; Ilkay Bozkurt; Jamal Wadi; Corneliu Popescu; Ilker Inanc Balkan; Safak Ozer-Balin; Tatjana Lejko Zupanc; Antonio Cascio; Irina Magdalena Dumitru; Aysegul Erdem; Gulden Ersoz; Meltem Tasbakan; Oday Abu Ajamieh; Fatma Sirmatel; Simin Florescu; Serda Gulsun; Hacer Deniz Ozkaya; Sema Sari; Selma Tosun; Meltem Avci; Yasemin Cag; Guven Celebi; Ayse Sagmak-Tartar; Sumeyra Karakus; Alper Sener; Arjeta Dedej; Serkan Oncu; Rosa Fontana Del Vecchio; Derya Ozturk-Engin; Canan Agalar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-06-11       Impact factor: 3.267

2.  Interactive clinical case: to give, or not to give, infective endocarditis prophylaxis.

Authors:  Shyam S Kothari
Journal:  Heart Asia       Date:  2017-01-06

3.  Temporal trends in infective endocarditis epidemiology from 2007 to 2013 in Olmsted County, MN.

Authors:  Daniel C DeSimone; Imad M Tleyjeh; Daniel D Correa de Sa; Nandan S Anavekar; Brian D Lahr; Muhammad R Sohail; James M Steckelberg; Walter R Wilson; Larry M Baddour
Journal:  Am Heart J       Date:  2015-07-17       Impact factor: 4.749

4.  Infective endocarditis: a tertiary referral centre experience from Turkey.

Authors:  Fahriye Vatansever Agca; Necmiye Demircan; Tezcan Peker; Hasan Ari; Kemal Karaagac; Ozlem Arican Ozluk; Mustafa Yilmaz; Erhan Tenekecioglu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

5.  An epidemiological study to define the recent clinical characteristics and outcomes of infective endocarditis in southern Turkey.

Authors:  Aynur Acibuca; Mustafa Yilmaz; Sefa Okar; Ebru Kursun; Onur Acilar; Abdullah Tekin; Yusuf Ziya Demiroglu; Ibrahim Haldun Muderrisoglu
Journal:  Cardiovasc J Afr       Date:  2021-04-07       Impact factor: 1.167

6.  Endocarditis in the Mediterranean Basin.

Authors:  F Gouriet; H Chaudet; P Gautret; L Pellegrin; V P de Santi; H Savini; G Texier; D Raoult; P-E Fournier
Journal:  New Microbes New Infect       Date:  2018-05-30

7.  Microbiological and clinical profile of infective endocarditis patients: an observational study experience from tertiary care center Karachi Pakistan.

Authors:  Uzma Shahid; Hasanat Sharif; Joveria Farooqi; Bushra Jamil; Erum Khan
Journal:  J Cardiothorac Surg       Date:  2018-09-15       Impact factor: 1.637

8.  Clinical characteristics of infective endocarditis in patients with antineutrophil cytoplasmic antibody or antiphospholipid antibody: a retrospective study in Shanghai.

Authors:  Zhuochao Zhou; Junna Ye; Jialin Teng; Honglei Liu; Xiaobing Cheng; Yue Sun; Yutong Su; Huihui Chi; Fan Wang; Chengde Yang; Wei Jin
Journal:  BMJ Open       Date:  2020-02-12       Impact factor: 2.692

9.  Microbiological profile and risk factors for in-hospital mortality of infective endocarditis in tertiary care hospitals of south Vietnam.

Authors:  Hoang M Tran; Vien T Truong; Tam M N Ngo; Quoc P V Bui; Hoang C Nguyen; Trung T Q Le; Wojciech Mazur; Eugene Chung; John M Cafardi; Khanh P N Pham; Hoang H N Duong; Thach Nguyen; Vu T Nguyen; Vinh N Pham
Journal:  PLoS One       Date:  2017-12-14       Impact factor: 3.240

10.  Simultaneous Brucella breast and pacemaker infection.

Authors:  Dima Ibrahim; Helene Dabbous; Yasmine Abi Aad; George F Araj; Nesrine A Rizk
Journal:  IDCases       Date:  2019-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.